When was Shapeshift Bio founded?

Shapeshift Bio was founded in 2025.

Where does Shapeshift Bio rank among its competitors?

Shapeshift Bio ranks 9th amongst 13 active competitors, only 1 of which is funded. Tolemy Bio, which secured $1.65M in May, 2026.

Who are the top competitors of Shapeshift Bio?

Shapeshift Bio's top competitors include Amnis, Tolemy Bio and Fennik Life Sciences. Among them, Tolemy Bio secured the most recent funding round in May, 2026.

Shapeshift Bio - 2026 Company Profile & Competitors

Shapeshift Bio is an unfunded company, founded in 2025. It operates as a Developer of hardware systems for feedback control of bioelectric patterns. Shapeshift Bio has not raised any funding yet. The company has 13 active competitors, including 1 funded and 2 that have exited. Its top competitors include companies like Amnis, Tolemy Bio and Fennik Life Sciences.

Company Details

Developer of hardware systems for feedback control of bioelectric patterns. The technology guides morphological outcomes by monitoring and regulating bioelectric communication within cell tissue. These systems assist in tissue generation and the management of biological processes. The development focuses on instrumentation for the real-time modulation of signals involved in cellular organization and physiological function.

Key Metrics

Founded Year

2025

Stage

Unfunded

Ranked

9^th among 13 active competitors

Similar Companies

Amnis & 11 more

View Shapeshift Bio's full profile

Shapeshift Bio has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shapeshift Bio include Amnis, Tolemy Bio and Fennik Life Sciences. Here is the list of Top 10 competitors of Shapeshift Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Amnis 1998, Seattle (United States), Acquired	Cell analysis solutions advancing cancer and cell biology research	$15.2M	Emerging Technology Partners, Washington Research Foundation ... & 6 others	38/100
2nd	Tolemy Bio 2024, Barcelona (Spain), Seed	Developer of artificial intelligence software for virtual cell biological simulation	$1.65M	Norrsken Evolve, JME Venture Capital & 5 others	31/100
3rd	Fennik Life Sciences 2016, Kansas City (United States), Unfunded	Innovative 3D cell culture solutions empowering biomedical research and drug discovery	-	-	22/100
4th	Human Regenerative Technologies 2016, El Segundo (United States), Unfunded	Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair	-	-	22/100
5th	Avisoft Bioacoustics 1990, Glienicke (Germany), Acquired	Manufacturer of ultrasound recording hardware and sound analysis software tools	-	-	20/100
6th	Humanrobotix 2021, United Kingdom, Unfunded	Developer of robotic interface for upper limb neuromotor research	-	-	16/100
7th	AjaxDNA Spain, Unfunded	Developer of biological intelligence software and cellular laboratory testing hardware	-	-	16/100
8th	Ishsystems 2019, West Des Moines (United States), Unfunded	Manufacturer of oxygen control systems for small animal research models	-	-	16/100
9th	Shapeshift Bio 2025, Unfunded	Developer of hardware systems for feedback control of bioelectric patterns	-	-	16/100
10th	Spikex United Kingdom, Unfunded	Developer of AI-powered sleep analysis system for animal research applications	-	-	16/100